{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["50(3)"],"submitter":["Kharel S"],"pubmed_abstract":["<h4>Objective</h4>The mean platelet volume (MPV) is a measure of platelet size, and it is considered a surrogate marker of platelet activation. Because the correlation between platelet count/size and lung cancer prognosis remains unclear, this meta-analysis comprehensively evaluated the prognostic significance of MPV among patients with lung cancer.<h4>Methods</h4>A systematic search of PubMed, Embase, Google Scholar, and additional sources of relevant studies were conducted with no language restrictions from inception to 7 May 2021. Overall survival (OS) and disease-free survival (DFS)/progression-free survival (PFS), as well as their hazard ratios (HR) and 95% confidence intervals (CIs), were pooled to evaluate the relationship between MPV and survival. The study protocol was registered "],"journal":["The Journal of international medical research"],"pagination":["3000605221084874"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8943633"],"repository":["biostudies-literature"],"pubmed_title":["Prognostic significance of mean platelet volume in patients with lung cancer: a meta-analysis."],"pmcid":["PMC8943633"],"pubmed_authors":["Rawat R","Kharel S","Shilpakar R","Shakya P","Shrestha S"],"additional_accession":[]},"is_claimable":false,"name":"Prognostic significance of mean platelet volume in patients with lung cancer: a meta-analysis.","description":"<h4>Objective</h4>The mean platelet volume (MPV) is a measure of platelet size, and it is considered a surrogate marker of platelet activation. Because the correlation between platelet count/size and lung cancer prognosis remains unclear, this meta-analysis comprehensively evaluated the prognostic significance of MPV among patients with lung cancer.<h4>Methods</h4>A systematic search of PubMed, Embase, Google Scholar, and additional sources of relevant studies were conducted with no language restrictions from inception to 7 May 2021. Overall survival (OS) and disease-free survival (DFS)/progression-free survival (PFS), as well as their hazard ratios (HR) and 95% confidence intervals (CIs), were pooled to evaluate the relationship between MPV and survival. The study protocol was registered ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Mar","modification":"2025-04-21T23:14:57.077Z","creation":"2025-04-05T19:05:16.403Z"},"accession":"S-EPMC8943633","cross_references":{"pubmed":["35313756"],"doi":["10.1177/03000605221084874"]}}